The infectious particles of hepatitis B virus are called Dane particles and consist of viral nucleic acid encapsulated within a core particle that is enveloped by virus-coded surface proteins. The major S protein constitutes a significant fraction of these surface proteins. In addition, there are two other related proteins (large S and middle S), but their role in envelope formation has not yet been elucidated. We modified the translation initiation codon ATG of each of the envelope proteins by site-directed mutagenesis and found that mutant genomes that did not produce one or two of these proteins were unable to form Dane particles. The particles released into the culture medium by such mutants did not carry DNA. Synthesis of virus-coded RNA still occurred normally, and core particles carrying DNA accumulated intracellularly. The DNA in such core particles was mostly in the double-stranded open circular form, in contrast to the normal situation in which the particles contain mostly RNA and its complementary single-stranded DNA or else contain linear DNA that is partially single stranded and otherwise duplex. The role of the large S and middle S proteins in the formation of Dane particles is discussed.
Infectious particles of hepatitis B virus (HBV) are usually called 42-nm particles or Dane particles and carry viral nucleic acid in core particles enveloped by three proteins, which are the large S (LS), middle S (MS), and major S (SS) proteins (39) . These three proteins are embedded in a lipid bilayer originating from the host cell. Among these proteins, the major component is SS; it is also often called HBV surface antigen (HBsAg) and consists of 226 amino acids. About half of SS is in the nonglycosylated form (p24), and the other half is in the glycosylated form (gp27) (10) . MS is coterminal with SS, having an additional 55-amino-acid extension at the N terminus. This extension polypeptide is called pre-S2. Depending on the extent of glycosylation, there are three forms of MS: p30, gp33, and gp36 (11, 12) . LS is also coterminal with SS and MS and is characterized by an additional 108-to 119-amino-acid extension (often called pre-Sl) at the N terminus of MS. There are also nonglycosylated (p39) and glycosylated (gp42) forms of LS (16, 38) . The structural relationships among the three envelope proteins and the location of their genes in the HBV genome are shown in Fig. 1 . In the blood stream of patients infected with HBV are also found the so-called 22-nm particles. These are small particles that consist of SS alone or SS and MS (13), but do not contain LS. Sometimes, tubular particles with a diameter of 22 nm are also observed, which are composed of SS, MS, and some LS. The small particles and tubular particles are "empty" envelopes that carry no core proteins or nucleic acids.
The roles and the functional relationships of SS, MS, and LS in particle formation are not yet understood. Since SS is the major component of the small particles and the envelope of Dane particles, it is likely to play a dominant role in particle formation in association with biological membranes. In fact, the SS alone produced in heterologous host cells is now widely used as a vaccine. Presumably, its membranebinding activity and ability to associate form the basis of the assembly mechanism (1) . The pre-S2 region of MS (and also * Corresponding author. LS) binds to polymerized human serum albumin (17, 28) and may act in the infection process of the virion (29, 44) . The pre-Sl region of LS is also suggested to play a role in the infection process (23, 24, 29) . In contrast to SS and MS, which separately or in combination can give rise to small particles (20, 33) . LS alone cannot form particles. When expressed alone, it remains bound to the cell membrane (3) , and when it is coexpressed it tends to inhibit the production of small particles (2, 25, 33) . In HBV-infected patients, the content of circulating pre-Si antigen is paralleled by that of viral DNA (24) , suggesting that the LS protein has a role in the assembly of Dane particles.
The structures of the three envelope proteins suggest that they interact with each other to allow the assembly of particles, but the mode of this interaction and the role that each protein plays in the assembly process have not yet been elucidated. We attempted to solve these problems by transfection studies with mutant genomes that were unable to produce one of the three proteins. The results showed that all three proteins are indispensable for the formation of Dane particles.
MATERIALS AND METHODS
Plasmid construction and preparation of mutants. A vector (M13mp8XB) that could be cleaved by BamHI and XhoI was constructed by inserting synthetic oligonucleotide linkers (5'-AGATCTCTCGAG-3' and 5'-CTCGAGAGATCT-3') into the SmaI site of M13mp8. A 1.9-kb BamHI-XhoI fragment of cloned HBV DNA carrying the ATGs for the pre-Sl and pre-S2 regions (7) (Fig. 1) was inserted into the BamHI-XhoI site of mp8XB (mp8XB-HB). The single-stranded mp8XB-HB was then used as a template for site-directed mutagenesis. Three synthetic mutagenic primers (5'-GCTA CAGCACGGGAGG-3', 5'-GACAAGGCACGGGGACG-3', and 5'-CTCAGGCCACGCAGTGG-3'), covering the translation start codon ATG for pre-SI, the in-phase ATG codon in the pre-Sl region, and the translation start codon ATG for pre-S2, respectively, were designated with ATG converted to ACG and used for mutagenesis according to the manual 20 ,g per dish by the Ca(PO4)2 precipitation method and a transfection kit (Cell Phect; Pharmacia). Usually five plates were used for one transfection experiment. After 12 h, the medium was withdrawn and cells were washed twice with serum-free DMEM, followed by incubation for 5 days with DMEM containing 10% fetal bovine serum, penicillin G (100 IU/ml), and streptomycin (100 ,g/ml).
Purification of particles released into the medium and assay for envelope proteins. The culture supernatants were pooled, clarified at 12,000 x g for 10 min, and then centrifuged through 15% sucrose-TNE ( mM NaCI, 5 mM EDTA) at 100,000 x g for 5 h at 10°C with a Hitachi SRP28SA rotor. The pellet was suspended in TNE and centrifuged through a 3.5-ml step gradient of CsCl (39 to 15% [wt/wt]) in TNE at 150,000 x g for 30 h at 10°C in a Hitachi RPS40T-141 rotor. Aliquots of 500 ,ul were collected from the bottom and assayed for HBsAg (see below). Fractions carrying a high HBsAg titer were then pooled and recentrifuged through a 25 and 23% (wt/wt) CsCl step gradient, and aliquots of 200 RI were collected and assayed for envelope proteins. The assay for envelope proteins was an enzyme immunoassay (EIA) with immobilized antiHBsAg (Abbott; Auszyme II), anti-pre-Sl, or anti-pre-S2 (18, 37) . The second antibody was anti-HBsAg antibody labeled with horseradish peroxidase. Other aliquots of the CsCl fractions were subjected to Southern blot analysis to examine HBV DNA. Also, some fractions carrying high HBsAg titers were concentrated and subjected to Western immunoblot analysis.
Purification of core particles. The transfected cells (3 x 106) were harvested and homogenized in TNE containing 0.1% Triton X-100 and 0.1% 2-mercaptoethanol and then centrifuged at 10,000 x g at 4°C for 20 min to eliminate nuclei and cell debris. The supernatant was centrifuged through 2.5 ml of 30% sucrose in TNE-0.1% Triton X-100-0.1% 2-mercaptoethanol at 150,000 x g for 18 h at 10°C in a Hitachi RPS40T-141 rotor. The pellet was then suspended in an aliquot (0.3 ml) of the same solution and recentrifuged through a 2.5-ml CsCl step gradient (39 to 19% [wtlwt] ) at 150,000 x g for 18 h at 10°C with the same rotor. Fractions of 200 ,1 were collected from the bottom, and HBV c and e antigens (HBcAg and HBeAg) were assayed with an Abbott HBeEIA kit.
Analysis of HBV DNA in particles released into the medium and in core particles. Aliquots from the CsCl fractions containing particles (peak fraction for either HBsAg or HBc/eAg) were diluted by adding 5 volumes of TE buffer (10 mM Tris-HCI [pH 7.8], 1 mM EDTA) with pronase E (1 mg/ml), yeast tRNA (0.1 mg), and 1% sodium dodecyl sulfate (SDS) and then incubated at 37°C for 3 h. Nucleic acid was extracted with phenol-chloroform (1:1), precipitated with ethanol, redissolved, and then subjected to Southern analyses with [a-32P]dCTP-labeled linearized HBV genomic DNA as the probe (7).
Detection of HBV surface antigens by Western blotting. The amount of HBsAg in each of the purified, concentrated samples (see purification of particles released into the medium) was adjusted to be equal and then diluted with an equal volume of 125 mM Tris-HCl (pH 6.8)-4% SDS-10% glycerol-0.02% bromophenol blue-4% 2-mercaptoethanol. The samples were then boiled for 5 min. The proteins were separated by 12.5% SDS-polyacrylamide gel electrophoresis and then subjected to Western blotting with Amersham's protein detection kit.
RESULTS
Experimental strategy. We and others (32, 36, 40, 43) have established a system in which HBV virions are produced from hepatoma-derived cell lines transfected with the cloned HBV genome. We adopted this system for elucidating the role of the LS and MS proteins by using mutant DNAs having ATG to ACG substitutions in the respective translation start codons. As the pre-Sl and the pre-S2 regions starting with the respective ATG codon overlap the DNA polymerase ORF that is translated by a different frame (9, 39) , each ATG was converted to ACG so that the resulting mutant genome coded for a polymerase with the same amino acid sequence. The mutant 1M had two point mutations, one in the pre-Sl start codon and the other in the 12th internal ATG codon. The mutant 2M had a mutation in the pre-S2 start codon, and the mutant 3M had all three mutations. Thus, 1M and 2M were expected to produce only MS and LS, respectively, whereas 3M was not expected to produce either LS or MS (Fig. 1) . Other viral functions, such as core particle formation, HBV DNA replication, and DNA packaging, were expected to be normal in these mutants, and this was confirmed by our study.
Each mutant HBV genome was converted into three tandemly arranged molecules (40) below, all the culture medium samples from 1M and 2M cells contained only small particles. In our in vitro transfection system, LS could be assembled into small particles together with SS, at least 2M and wild-type DNA, in contrast to the in vivo experience (13) . Mixed transfection with 1M and 2M gave rise to patterns essentially the same as with W (Fig. 2,  lane 1M+2M) . Figure 3 shows the time course of production of LS, MS, and SS as detected by antibodies against pre-Sl, pre-S2, and SS, respectively. The patterns from the wild type and mutants, except for the relevant mutation, were almost superimposable. Therefore, the absence of pre-Sl or pre-S2 synthesis had no effect on the production of other envelope proteins. This figure also demonstrates that HBeAg, a corerelated polypeptide, was produced with identical kinetics.
Northern (RNA) blotting profiles (Fig. 4) (Fig. 5) . The banding profiles were all the same, and the density agreed with the reported value (14) . In addition, the amount of core particles recovered from the same number of cells was roughly identical in each case. Here again, the mutations did not affect the production of core proteins and core particles. As the core particles were not enveloped for release in the mutants (see below), it might be expected that some of the particles or polypeptides would accumulate intracellularly, but this was not the case. Possibly, there is a mechanism that does not allow such excessive accumulation to occur.
Formation of small particles but not Dane particles. As noted earlier, the envelope proteins LS, MS, and SS are not individually released into the culture medium as free polypeptides, but are released after assembly into particles. The small particles predominate, and Dane particles are in the minority. To examine the nature of the particles produced and released into the culture medium by the mutant-transfected cells, we collected particles from the medium and banded them in CsCl density gradients. Figure 6 shows the density gradient distribution profiles obtained with antibodies to detect SS, MS, and LS (anti-SS antibody, anti-pre-S2 antibody, and anti-pre-Sl antibody, respectively). Most of the antigens banded at a density of about 1.20 to 1.25 gIml (15) and showed essentially the same pattern irrespective of which sample was tested, except for loss of the protein under the control of the mutated start codon. The profiles of LS and MS were superimposable with the profile of SS.
To examine whether or not the particles released included Dane particles, we took each fraction on the heavier side of the major peak in the CsCl density gradient and examined them individually for the presence of viral DNA by Southern analysis. In this type of analysis, the Dane particles that contain DNA will band at a slightly heavier position (1.25 g/ml), whereas the small particles that do not contain DNA band at a lighter position (1.20 to 1.22 g/ml) (15) . The result with the wild-type preparation is shown in Fig. 7A . As expected, fractions 11 through 13 of this sample carried the w cscl Fr. Na 11 12 13 16.4--m iM 11 12 13 viral DNA. On the other hand, the corresponding fractions prepared from mutants 1M, 2M, and 3M showed no HBV DNA (data not shown). To confirm this observation, we pooled the peak fractions of each sample in Fig. 6 (from 1.18 to 1.28 g/ml), concentrated them, and tested them again by Southern blotting analysis for the possible presence of small amounts of HBV DNA. Again, no DNA was detected in the samples from any of the mutants (Fig. 7B) . The control sample (lane 1M+2M) that had been transfected with complementing mutants produced particles containing HBV DNA. These observations strongly suggest that in the absence of LS and/or MS, virions carrying DNA cannot be formed, or else their formation is reduced to a nondetectable level. Although we have not been able to show by electron microscopy that the particles in the medium are small particles, their sedimentation behavior was in complete agreement with that of such particles (data not shown). Thus, we propose that both LS and MS are necessary for Dane particle formation but not for the other viral functions tested so far, including small-particle formation.
Viral DNA in the intracellular core particles. Viral pregenome RNA is packaged into core particles and reversetranscribed into DNA (35) . Although the mutants that were unable to form one of the envelope proteins could not make double-shelled Dane particles that contained viral DNA, the intracellular core particles produced by these mutant-transfected cells did contain viral DNA. The viral nucleic acid is known to have one of the following three forms: a full-length linear minus-strand single-stranded DNA molecule (S DNA), a linear form of the full-length minus-strand DNA that is partially duplexed with an incompletely synthesized plus-strand DNA (D1), and circular DNA of the same composition (D2) (40) . Sometimes, molecules of almost completely double-stranded, relaxed circular form called D3 DNA are also detected (4, 8, 30) . We examined the content of viral DNA molecules and their molecular shape in the banded core particles shown in Fig. 5 . The amount of S DNA was roughly the same among the different samples, but the contents of D1, D2, and D3 DNA showed significant variations (Fig. 8) (44) . LS alone could not be assembled into small particles under similar conditions, and it even hindered small-particle formation when coexpressed at high levels with SS (26, 33 Multiple regions of LS, MS, and SS may be involved in these interactions. The two models are not mutually exclusive, e.g., the restricted region for interaction could be formed only through the correct arrangement of the three proteins producing a correctly curved inner side of the envelope.
The core particles from the cytoplasm of cells transfected with mutant 1M, 2M, or 3M carried viral DNA, most of which was in the D3 form. D3 molecule seemed to consist of a full-length negative-strand DNA and an almost full-length positive-strand DNA which was not in the covalently closed circular form, because the D3 band in the Southern analyses shifted to the full-length double-stranded linear DNA marker of 3.2 kb when digested with a restriction enzyme which cuts at one site in HBV DNA, such as BamHI and XhoI (Fig. 1) .
In addition, when such D3 DNA was heat denatured and subjected to Southern analyses, the majority of the HBV DNA banded at the position for single-stranded 3.2-kb DNA and hybridized with both the plus-strand-specific probe and the minus-strand-specific probe (data not shown). In contrast, S, D1, and D2 DNA molecules were abundant inside the core particles made by transfection with wild-type DNA.
How can the presence or the absence of LS and MS affect the relative ratio of the different HBV DNA molecules in the core particles? According to the current scheme of HBV DNA synthesis (9, 19, 31, 35) , S DNA is synthesized first and then converted into D1, D2, and finally D3 DNA. Since the D1 and D2 forms differ only in whether they "cohere" at the cohesive-end region, they do not represent different steps in the replication pathway. It may be that the simultaneous production of LS and MS proteins inhibits the conversion of viral DNA from D1 and D2 to D3, or else that D3 develops when the viral DNA is packaged into core particles and then remains for a long period in the cytoplasm without being enveloped, which suggests physiological differences between the wild type and mutants 1M, 2M, and 3M. Without an envelope, the influx of substrates will continue and most of the viral DNA will eventually become fully double stranded. A clue to determining which of these alternatives is correct may be available through examining whether the pre-S region interacts directly with core particles. In this context, it is interesting that the D3 form of viral DNA is abundant in both the core and Dane-like particles of duck hepatitis virus (42) .
